Stemline Therapeutics Reports Fourth Quarter 2019 Financial Results

Ads

You May Also Like

Epizyme Reports Third Quarter 2017 Operating Results and Company Updates

Company Scheduled for First FDA Interaction for Tazemetostat in NHL in 4Q17 Chief Medical ...

Telix Pharmaceuticals and JFE Announce Japanese Radiopharmaceutical Manufacturing Partnership

MELBOURNE, Australia and TOKYO, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) ...

Kura Oncology to Present at Oppenheimer 28th Annual Healthcare Conference

SAN DIEGO, March 16, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage ...